At the final follow-up ( 24 months ) , there was a significant relief in pain ( P < 0.05 ) and clinical joint symptoms as measured by the Lequesne index ( P < 0.05 ) and Western Ontario and McMaster Universities Arthritis Index ( P < 0.05 ) in the treatment group .